Showing results (801-810 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|November 30, 2024
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trialSanjay Ramakrishnan, Richard E K Russell, Hafiz R Mahmood, et al.
The Lancet. Respiratory Medicine|November 16, 2024
Clinical remission attainment, definitions, and correlates among patients with severe asthma treated with biologics: a systematic review and meta-analysisAmy Shackleford, Liam G Heaney, Charlene Redmond, et al.
The Lancet. Respiratory Medicine|October 2, 2025
Reframing remission in severe asthma: a conceptual framework for distinguishing disease activity versus damageCeleste Porsbjerg, Hitasha Rupani, John D Brannan, et al.
The Lancet. Respiratory Medicine|October 1, 2025
Durvalumab, carboplatin, and etoposide in patients who are treatment-naive with extensive-stage small-cell lung cancer and poor performance status (NEJ045A): a single-arm phase 2 trialTetsuhiko Asao, Yu Saida, Satoshi Watanabe, et al.
The Lancet. Respiratory Medicine|December 7, 2019
Continuous positive airway pressure versus standard care for the treatment of people with mild obstructive sleep apnoea (MERGE): a multicentre, randomised controlled trialAlison J Wimms, Julia L Kelly, Christopher D Turnbull, et al.
The Lancet. Respiratory Medicine|September 11, 2020
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trialLiam G Heaney, John Busby, Catherine E Hanratty, et al.
The Lancet. Respiratory Medicine|March 21, 2020
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysisZhiyi Lan, Nafees Ahmad, Parvaneh Baghaei, et al.
The Lancet. Respiratory Medicine|July 31, 2021
Early diagnosis of fibrotic interstitial lung disease: challenges and opportunitiesPaolo Spagnolo, Christopher J Ryerson, Rachel Putman, et al.
The Lancet. Respiratory Medicine|November 21, 2022
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort studyMatan Yechezkel, Merav Mofaz, Amichai Painsky, et al.
The Lancet. Respiratory Medicine|June 12, 2022
Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trialRolando Ochoa-Azze, Arturo Chang-Monteagudo, Yanet Climent-Ruiz, et al.
Pageof 104